Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not bashing XKEM - I wish you well, just pointing out that RSI is in the danger zone, but if you are happy there, I also am happy for you. I'll take VSGN in the buy zone of 20!
GLTY
VSGN - oh my- Naked short list? SQUEEZE? YESSSSSSS - read
>Jun 30, 2006 (M2 PRESSWIRE via COMTEX) -- www.buyins.net, announced today that these select companies have been on the NASDAQ, AMEX and NYSE naked short threshold list for 13 consecutive trading days: Advantage Energy Incm Fd (NYSE: AAV), Luna Innovations Incorporated (NASDAQ: LUNA), Tim Hortons Inc (NYSE: THI), Vasogen Inc. (NASDAQ: VSGN), Aegis Assessments, Inc. (OTCBB: AGSI), Provectus Pharmaceuticals, Inc. (OTCBB: PVCT)....."
Here is VSGN oversold chart and link to upcoming Celacade commercialization NEWS!
http://stockcharts.com/h-sc/ui?s=vsgn&p=D&yr=0&mn=6&dy=0&id=p87462693062
"We are currently completing the analysis of the ACCLAIM data in preparation for releasing full study results at this venue and at the World Congress of Cardiology in Barcelona, Spain, both in September. Based on our ongoing review of the data, we also look forward to providing an update on our plans to advance the commercial development of Celacade during our second quarter conference call in mid-July."
http://biz.yahoo.com/prnews/060629/to263.html?.v=31
XKEM vs VSGN? Do you want RSI of 80 or RSI of 20? Anyone buying XKEM here must really have guts to buy the RSI 80.
Vasogen just got pummeled on Phase III study (the final studies of drug trials) results.
However read this!
this endpoint was met for the subgroup of 692 patients with New York Heart Association (NYHA) Class II chronic HF (39.1% risk reduction, p(equal sign)0.0003). The Company is continuing data analysis, and complete results for the ACCLAIM study are scheduled to be presented at the World Congress of Cardiology 2006, being held from September 2-6 in Barcelona, Spain.
ADVERTISEMENT
"While ACCLAIM was a neutral study based on the total patient population that included NYHA Class II, III and IV patients, a pre-specified analysis in the subgroup of nearly 700 patients with NYHA Class II heart failure showed a powerful and very encouraging result," said Dr. James Young, Chairman, Division of Medicine at the Cleveland Clinic Foundation and Chairman of the Steering Committee for the ACCLAIM trial. "Celacade's broad-spectrum anti- inflammatory effects may be more beneficial in those patients who have not advanced to late stage disease, but who are at risk for doing so. From a healthcare system perspective, a therapy that reduces the rate of hospitalization in this large and underserved patient population would be very valuable. The therapy was also very well tolerated by patients, and in my experience, was better tolerated than many drug therapies used in heart failure. I would like to thank the investigators, my fellow Steering Committee members, the Data and Safety Monitoring Board and the Central Endpoints Committee for their diligent efforts in carrying out this very important, necessary, and well-executed study."
The double blind, placebo-controlled ACCLAIM study randomized 2,414 subjects with advanced chronic HF at 176 clinical centers in seven countries. The placebo (n(equal sign)1,207) and Celacade (n(equal sign)1,207) groups were well balanced for all important baseline characteristics, including demographics, ejection fraction, NYHA classification, concomitant medical conditions and medications, automatic implantable cardioverter defibrillators (AICDs) and use of cardiac resynchronization therapy (CRT).
Internet fireworks link- enjoy - happy 4th all!
http://cyberfireworks.com/lv.htm
VSGN - commercialization plans to be announced in a few days...
An oral presentation at a HFSA late breaker clinical trial session provides another excellent opportunity to share the ACCLAIM results with the international cardiology community," stated David Elsley, President and CEO of Vasogen. "We are currently completing the analysis of the ACCLAIM data in preparation for releasing full study results at this venue and at the World Congress of Cardiology in Barcelona, Spain, both in September. Based on our ongoing review of the data, we also look forward to providing an update on our plans to advance the commercial development of Celacade during our second quarter conference call in mid-July."
http://biz.yahoo.com/prnews/060629/to263.html?.v=31
VSGN - here are the study results - does it sound like they may still market the drug? I believe 39% patient improvement in chronic heart failure is actually great news! This was way way oversold for the potential, imo.
While the ACCLAIM study did not reach the primary endpoint of significantly reducing the risk of death and cardiovascular hospitalization in the total population, this endpoint was met for the subgroup of 692 patients with New York Heart Association (NYHA) Class II chronic HF (39.1% risk reduction, p(equal sign)0.0003). The Company is continuing data analysis, and complete results for the ACCLAIM study are scheduled to be presented at the World Congress of Cardiology 2006, being held from September 2-6 in Barcelona, Spain.
"While ACCLAIM was a neutral study based on the total patient population that included NYHA Class II, III and IV patients, a pre-specified analysis in the subgroup of nearly 700 patients with NYHA Class II heart failure showed a powerful and very encouraging result," said Dr. James Young, Chairman, Division of Medicine at the Cleveland Clinic Foundation and Chairman of the Steering Committee for the ACCLAIM trial. "Celacade's broad-spectrum anti- inflammatory effects may be more beneficial in those patients who have not advanced to late stage disease, but who are at risk for doing so. From a healthcare system perspective, a therapy that reduces the rate of hospitalization in this large and underserved patient population would be very valuable. The therapy was also very well tolerated by patients, and in my experience, was better tolerated than many drug therapies used in heart failure. I would like to thank the investigators, my fellow Steering Committee members, the Data and Safety Monitoring Board and the Central Endpoints Committee for their diligent efforts in carrying out this very important, necessary, and well-executed study."
The double blind, placebo-controlled ACCLAIM study randomized 2,414 subjects with advanced chronic HF at 176 clinical centers in seven countries. The placebo (n(equal sign)1,207) and Celacade (n(equal sign)1,207) groups were well balanced for all important baseline characteristics, including demographics, ejection fraction, NYHA classification, concomitant medical conditions and medications, automatic implantable cardioverter defibrillators (AICDs) and use of cardiac resynchronization therapy (CRT).
The time to death or first cardiovascular hospitalization (the primary endpoint) was not significantly different between the Celacade and placebo groups in the intention to treat (ITT) population (p(equal sign)0.24), nor was there any significant difference between treatment groups for either of the components of the primary endpoint.
In the pre-specified subgroup of patients with NYHA Class II chronic HF (n(equal sign)692), the time to death or first cardiovascular hospitalization was significantly reduced in the Celacade group (n(equal sign)360) compared to the placebo group (n(equal sign)332) by 39.1% (p(equal sign)0.0003).
In addition to a number of secondary endpoints in the study, changes in high-sensitivity C-reactive protein (hs-CRP) were measured at baseline and 26 weeks. While changes in hs-CRP directionally favoured the Celacade group, the between group differences did not reach statistical significance in the ITT population.
Celacade was shown to be well tolerated in this patient population, who were receiving standard-of-care medications for heart failure, including diuretics, beta-blockers and ACE-inhibitors. There were no significant between- group differences for any serious adverse events.
"We are obviously disappointed that ACCLAIM did not achieve its primary endpoint, however, we are very encouraged by the strong effects seen in NYHA Class II patients," stated David Elsley, President and CEO of Vasogen. "As the Steering Committee prepares for presentation of the full results at the upcoming World Congress of Cardiology in September, we will be completing the analysis of the ACCLAIM data and reviewing the results with regulators and prospective partners. I want to sincerely thank the patients who participated in the study, the Steering Committee, the members of the Data and Safety Monitoring Board and Central Endpoints Committee, and all the clinical investigators and study coordinators for their significant efforts in conducting the ACCLAIM study."
http://biz.yahoo.com/prnews/060626/to179.html?.v=30
VSGN - Nasdaq biotech with RSI oversold - The study results are not nearly as bad as the market assumed, imo.
Sure, the drug won't cure end stage heart failure, but class II heart failure study data has positive data.
So VSGN looks to be headed back to dollar land, closed today at .49.
http://stockcharts.com/h-sc/ui?s=VSGN&p=D&yr=0&mn=6&dy=0&id=p08370054865
VSGN - Nasdaq biotech with RSI oversold - The study results are not nearly as bad as the market assumed, imo.
Sure, the drug won't cure end stage heart failure, but class II heart failure has positive data.
So VSGN looks to be headed back to dollar land, closed today at .49.
http://stockcharts.com/h-sc/ui?s=VSGN&p=D&yr=0&mn=6&dy=0&id=p08370054865
VSGN - Vasogen - RSI play - link---
http://stockcharts.com/h-sc/ui?s=VSGN&p=D&b=5&g=0&id=p72219258820
Way way oversold for the study results published, imo.
Look out, this one is bouncing!
I bought VSGN just because their study results were better than the stock reaction to the studies!!
Could thestockster be loading VSGN today, heavy accumulation pattern noticed, and it fits their type of stock to recommend.
A beaten down Nasdaq.
VSGN - RSI oversold play! .50 - great entry!
WTVN - internet TV - Worldwide - .0003 is a slam dunk, imo.
Take a few minutes to watch WTVN TV on your computer this weekend. Works really well, content needs upgrading and some Subscriber numbers need to be released, but at this price, may be worth a million shares or so, imo.
WTVN - .0002 to .0003 - won't have to run far to double!
WTVN= the next sub sub sub runner
Yahoo has a pick board.... here is the link, fwiw.
http://messages.yahoo.com/bbs?.mm=FNNS&action=l&board=4686678&tid=fallondinvesthistory&a...
I guess WTVN needs to update subscriber or revenues instead of eyeballs. But soon I think we might get that news!
WTVN's PR - 100 Countries Tune in to Wi-Fi TV
Thursday June 29, 10:00 am ET
Global TV Delivery Over the Internet Arrives as TV Looks to the Internet Audience
NEWPORT BEACH, CA--(MARKET WIRE)--Jun 29, 2006 -- Viewers in over 100 countries have tuned in to the online TV web site www.Wi-FiTV.com, Wi-Fi TV Inc. (Other OTC:WTVN.PK - News) announced today. Wi-Fi TV delivers hundreds of live TV channels and live chat, live webcams, on-demand content and current news and weather for dozens of countries and topics. Specialty channels available on Wi-Fi TV include those devoted to Music Video, News, Sports, Religions and other topics.
Starting immediately, viewers are currently tracked by the independent NeoTracker and the numbers for each country are visible on the Wi-Fi TV home page. In addition, viewers can scroll their mouse over the country flags and, as they do, a small map will appear showing where each country is located on the globe.
The advent of global TV delivery, as exemplified by www.Wi-FiTV.com, comes at a time when traditional TV programmers are looking to the Internet as a new means of delivering their content. Wi-Fi TV, which has been in business for approximately ten years, has long been an innovator in the delivery of video over the Internet. They delivered the first online movie to a global Internet audience in December 1995. They also delivered the first online text where type size could be altered by the viewer and pages could be turned without scrolling, the first video to a PocketPC® (preceding the inclusion of the WindowsMedia® player in PocketPCs), the first wireless over-the-Internet delivery of a movie to a laptop computer (in Sweden), and other Internet firsts.
Wi-Fi TV now offers viewers several options to sample its array of live online TV and other features available at www.Wi-FiTV.com.
There is a free five minute trial with no sign-up required, a free 14 day trail and a choice of monthly recurring subscriptions for $2.95 or a annual subscription for $24.95. Members get unlimited, no additional cost access to hundreds of channels and other features.
About Wi-Fi TV Inc.
Wi-Fi TV can be seen over the Internet in the United States, Latin America and globally. More than 200 channels of live TV programming, Country and Category specific breaking news and free voice over IP phone calls are available at www.Wi-FiTV.com.
Wi-Fi TV Inc. has opened a new content and technology demo room for the press in Newport Beach, California. For further information, contact Colby Marceau, 949-716-9397, info@wi-fitv.com.
WTVN had a great PR today and the stock barely responded. Maybe it will be a delayed reaction, lol!
In case you missed the WTVN news....
Press Release Source: Wi-Fi TV, Inc.
100 Countries Tune in to Wi-Fi TV
Thursday June 29, 10:00 am ET
Global TV Delivery Over the Internet Arrives as TV Looks to the Internet Audience
NEWPORT BEACH, CA--(MARKET WIRE)--Jun 29, 2006 -- Viewers in over 100 countries have tuned in to the online TV web site www.Wi-FiTV.com, Wi-Fi TV Inc. (Other OTC:WTVN.PK - News) announced today. Wi-Fi TV delivers hundreds of live TV channels and live chat, live webcams, on-demand content and current news and weather for dozens of countries and topics. Specialty channels available on Wi-Fi TV include those devoted to Music Video, News, Sports, Religions and other topics.
Starting immediately, viewers are currently tracked by the independent NeoTracker and the numbers for each country are visible on the Wi-Fi TV home page. In addition, viewers can scroll their mouse over the country flags and, as they do, a small map will appear showing where each country is located on the globe.
The advent of global TV delivery, as exemplified by www.Wi-FiTV.com, comes at a time when traditional TV programmers are looking to the Internet as a new means of delivering their content. Wi-Fi TV, which has been in business for approximately ten years, has long been an innovator in the delivery of video over the Internet. They delivered the first online movie to a global Internet audience in December 1995. They also delivered the first online text where type size could be altered by the viewer and pages could be turned without scrolling, the first video to a PocketPC® (preceding the inclusion of the WindowsMedia® player in PocketPCs), the first wireless over-the-Internet delivery of a movie to a laptop computer (in Sweden), and other Internet firsts.
Wi-Fi TV now offers viewers several options to sample its array of live online TV and other features available at www.Wi-FiTV.com.
There is a free five minute trial with no sign-up required, a free 14 day trail and a choice of monthly recurring subscriptions for $2.95 or a annual subscription for $24.95. Members get unlimited, no additional cost access to hundreds of channels and other features.
About Wi-Fi TV Inc.
Wi-Fi TV can be seen over the Internet in the United States, Latin America and globally. More than 200 channels of live TV programming, Country and Category specific breaking news and free voice over IP phone calls are available at www.Wi-FiTV.com.
Wi-Fi TV Inc. has opened a new content and technology demo room for the press in Newport Beach, California. For further information, contact Colby Marceau, 949-716-9397, info@wi-fitv.com.
ADVERTISEMENT
Forward-Looking Statements
Any statements made in this press release which are not historical facts contain certain forward-looking statements; as such term is defined in the Private Security Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. The actual results of the specific items described in this release, and the company's operations generally, may differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company's dependence on third parties, general market and economic conditions, technical factors, the availability of outside capital, receipt of revenues and other factors, many of which are beyond the control of the company. The company disclaims any obligation to update information contained in any forward-looking statement. This press release shall not be deemed a general solicitation.
Contact:
Contact:
Colby Marceau
949-716-9397
Email Contact
Wi-Fi TV
949-675-5011
WTVN - here comes the VOLUME! .0003's going fast!
WTVN - WORLDWIDE audience - those Mexican Visa cards work just as good as USA cards, lol....
You better believe this story will get bigger!
Press Release Source: Wi-Fi TV, Inc.
100 Countries Tune in to Wi-Fi TV
Thursday June 29, 10:00 am ET
Global TV Delivery Over the Internet Arrives as TV Looks to the Internet Audience
NEWPORT BEACH, CA--(MARKET WIRE)--Jun 29, 2006 -- Viewers in over 100 countries have tuned in to the online TV web site www.Wi-FiTV.com, Wi-Fi TV Inc. (Other OTC:WTVN.PK - News) announced today. Wi-Fi TV delivers hundreds of live TV channels and live chat, live webcams, on-demand content and current news and weather for dozens of countries and topics. Specialty channels available on Wi-Fi TV include those devoted to Music Video, News, Sports, Religions and other topics.
Starting immediately, viewers are currently tracked by the independent NeoTracker and the numbers for each country are visible on the Wi-Fi TV home page. In addition, viewers can scroll their mouse over the country flags and, as they do, a small map will appear showing where each country is located on the globe.
The advent of global TV delivery, as exemplified by www.Wi-FiTV.com, comes at a time when traditional TV programmers are looking to the Internet as a new means of delivering their content. Wi-Fi TV, which has been in business for approximately ten years, has long been an innovator in the delivery of video over the Internet. They delivered the first online movie to a global Internet audience in December 1995. They also delivered the first online text where type size could be altered by the viewer and pages could be turned without scrolling, the first video to a PocketPC® (preceding the inclusion of the WindowsMedia® player in PocketPCs), the first wireless over-the-Internet delivery of a movie to a laptop computer (in Sweden), and other Internet firsts.
Wi-Fi TV now offers viewers several options to sample its array of live online TV and other features available at www.Wi-FiTV.com.
There is a free five minute trial with no sign-up required, a free 14 day trail and a choice of monthly recurring subscriptions for $2.95 or a annual subscription for $24.95. Members get unlimited, no additional cost access to hundreds of channels and other features.
About Wi-Fi TV Inc.
Wi-Fi TV can be seen over the Internet in the United States, Latin America and globally. More than 200 channels of live TV programming, Country and Category specific breaking news and free voice over IP phone calls are available at www.Wi-FiTV.com.
Wi-Fi TV Inc. has opened a new content and technology demo room for the press in Newport Beach, California. For further information, contact Colby Marceau, 949-716-9397, info@wi-fitv.com.
ADVERTISEMENT
Forward-Looking Statements
Any statements made in this press release which are not historical facts contain certain forward-looking statements; as such term is defined in the Private Security Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. The actual results of the specific items described in this release, and the company's operations generally, may differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company's dependence on third parties, general market and economic conditions, technical factors, the availability of outside capital, receipt of revenues and other factors, many of which are beyond the control of the company. The company disclaims any obligation to update information contained in any forward-looking statement. This press release shall not be deemed a general solicitation.
Contact:
Contact:
Colby Marceau
949-716-9397
Email Contact
Wi-Fi TV
949-675-5011
WTVN - is a sleeping giant, bigger than BKMP, imo.
Anyone else adding WTVN at this .0003 level?
WTVN - the rollout continues - shhhhhh - dirt cheap stock!
SNIO - early trades hitting now - dividend play - the next PTSC?
Maybe - but 31 million newly purchased shares at .02 to .022 will be avaliable for sale at 50% profit as soon as it crosses .03! Then add the daytraders taking profits....
IMNR
27-Jun-2006
Unregistered Sale of Equity Securities
Item 3.02 Unregistered Sales of Equity Securities.
As previously reported, in 2006 we closed a private placement of secured convertible notes and warrants to accredited investors. The notes had an aggregate original principal amount of $8,000,000. The conversion price of the notes is $0.02 per share. The noteholders also received a total of 1,200,000,000 warrants to purchase our common stock at $0.02 per share.
On June 21, 2006 four noteholders exercised the first tranche of their warrants at $0.02 per share by paying the total exercise price of $352,500 for 17,625,000 shares of our common stock.
On June 23, 2006 one noteholder exercised the first tranche of its warrants at $0.02 per share by paying the total exercise price of $225,000 for 11,250,000 shares of our common stock.
On June 23, 2006, two noteholders converted $400,000 of outstanding principal balance plus accrued interest of $9,600.00 into 20,480,000 shares of common stock pursuant to the terms of their notes at $0.02 per share.
The 28,875,000 warrant exercise shares and the 20,480,000 note conversion shares and were issued to the accredited investor noteholders pursuant to the Securities Act Section 4(2) and Section 3(a)(9) registration exemptions, respectively.
As previously reported, our placement agent in the 2006 Private Placement, Spencer Trask Ventures, Inc. ("STVI") is entitled to receive $0.01 and an additional seven-year placement agent warrant for each five noteholder warrants which are exercised. The exercise price of the additional placement agent warrants will be at $0.02 per share. STVI, which is an affiliate of Kevin Kimberlin, who is a director and major stockholder of us, has allocated a portion of the additional placement agent warrants to various brokers and employees and its parent company. As a result of the exercise of 28,875,000 noteholder warrants as described above, STVI became entitled to $57,750 in cash and 5,775,000 additional placement agent warrants. These additional placement agent warrants will be issued to STVI and its assignees pursuant to the Securities Act Section 4(2) registration exemption.
After the June 23, 2006 note conversions, the aggregate outstanding principal balance of the notes is $6,707,500.
After the June 23, 2006 warrant exercise, the aggregate gross proceeds from the private placement warrant exercises is $5,421,375.
For your further information, TheStockster.com purchased 3,000,000 free trading shares of IMNR in the open market prior to the mention of IMNR on TheStockster.com website during the period from June 20 2006, to June 28, 2006, and paid a total of $ 67,500 or $ 0.0225 per/share on average for the entire position it acquired.
http://thestockster.com/wp/?page_id=5
SNIO - Cash dividend- Payble June 30th shareholders of record. I assume you have to be in by close today to get the dividend.
Here is the PR...
Press Release Source: Senticore, Inc.
Senticore Announces Dividend and Application to Change Its Name to Integrative Health Technologies, Inc.
Wednesday June 28, 7:00 am ET
SAN ANTONIO, June 28 /PRNewswire-FirstCall/ -- Senticore, Inc. (OTC Bulletin Board: SNIO - News) has declared its first dividend in the history of the company. The cash dividend will be distributed to all shareholders of record on close of business on June 30, 2006. The amount and timing of the dividend will be based on funds derived from sale of its 882,353 shares in AdZone Research, Inc., which the company received December 29, 2004 from a joint venture transaction with AdZone. The acquisition and intent to dividend the shares was announced in the company's Security and Exchange Commission's filings of Forms 10-KSB for 2004 and 2005 and was contingent upon AdZone's registration of the shares or the application of Rule 144.
Dividend
"While questions may be raised as to the wisdom of distributing this asset as a dividend in light of the company's current liabilities and the absence of any net profits since the company was formed in 1999," said Gilbert R. Kaats, Senticore's CEO, "there were a number of considerations that led to this decision. These include:
(1) we wanted to honor the commitment the previous management made to the
shareholders,
(2) the business of AdZone does not fit Senticore's strategic focus on
healthcare and nutrition,
(3) a review of Senticore's financials for the second quarter of 2006 has
revealed that the company has sufficient liquid assets to offset all
of its current liabilities, and
(4) Senticore's increased assets suggest that for the first time in the
history of the company, it will report a net profit for the second
quarter of 2006."
Name Change
Application for a name change from Senticore to Integrative Health Technologies is consistent with Senticore's increased emphasis on the acquisition of healthcare and nutritional portfolio companies. Although incomplete at this time, additional information on the company's healthcare emphasis can be found on it website, www.ihtglobal.com .
Forward-Looking Statement: Statements that are not historical facts are forward-looking statements. The Company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are necessarily estimates reflecting the Company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors, factors that could cause actual results to differ materially from those estimated by the Company. They include, but are not limited to, government regulation, managing and maintaining growth, and the effect of adverse publicity, litigation, competition and other factors that may be identified from time to time in the Company's public announcements.
Contact Person: Gilbert R. Kaats or Samuel C. Keith
Senticore, Inc.
(210) 824.4416
--------------------------------------------------------------------------------
Source: Senticore, Inc.
Good morning. SNIO - cash dividend, must buy today, could be strong open through close, imo...
SNIO - Today's penny runner - take a look at the chart and the NEWS - and see why it's up 50% already and looks to be going for 300% by close tomorrow with this news...
http://stockcharts.com/h-sc/ui?s=SNIO&p=D&yr=0&mn=3&dy=0&id=p13721477370
Press Release Source: Senticore, Inc.
Senticore Announces Dividend and Application to Change Its Name to Integrative Health Technologies, Inc.
Wednesday June 28, 7:00 am ET
SAN ANTONIO, June 28 /PRNewswire-FirstCall/ -- Senticore, Inc. (OTC Bulletin Board: SNIO - News) has declared its first dividend in the history of the company. The cash dividend will be distributed to all shareholders of record on close of business on June 30, 2006. The amount and timing of the dividend will be based on funds derived from sale of its 882,353 shares in AdZone Research, Inc., which the company received December 29, 2004 from a joint venture transaction with AdZone. The acquisition and intent to dividend the shares was announced in the company's Security and Exchange Commission's filings of Forms 10-KSB for 2004 and 2005 and was contingent upon AdZone's registration of the shares or the application of Rule 144.
Dividend
"While questions may be raised as to the wisdom of distributing this asset as a dividend in light of the company's current liabilities and the absence of any net profits since the company was formed in 1999," said Gilbert R. Kaats, Senticore's CEO, "there were a number of considerations that led to this decision. These include:
(1) we wanted to honor the commitment the previous management made to the
shareholders,
(2) the business of AdZone does not fit Senticore's strategic focus on
healthcare and nutrition,
(3) a review of Senticore's financials for the second quarter of 2006 has
revealed that the company has sufficient liquid assets to offset all
of its current liabilities, and
(4) Senticore's increased assets suggest that for the first time in the
history of the company, it will report a net profit for the second
quarter of 2006."
Name Change
Application for a name change from Senticore to Integrative Health Technologies is consistent with Senticore's increased emphasis on the acquisition of healthcare and nutritional portfolio companies. Although incomplete at this time, additional information on the company's healthcare emphasis can be found on its website, www.ihtglobal.com .
SNIO - its Running!
SNIO - HOD - Huge ARCA bid now!
SNIO - cash dividend, but today is last day to buy the stock and get the dividend.
http://biz.yahoo.com/prnews/060628/law013.html?.v=63
SNIO - Kicker news out - here is a recap...
Dividend
"While questions may be raised as to the wisdom of distributing this asset as a dividend in light of the company's current liabilities and the absence of any net profits since the company was formed in 1999," said Gilbert R. Kaats, Senticore's CEO, "there were a number of considerations that led to this decision. These include:
(1) we wanted to honor the commitment the previous management made to the
shareholders,
(2) the business of AdZone does not fit Senticore's strategic focus on
healthcare and nutrition,
(3) a review of Senticore's financials for the second quarter of 2006 has
revealed that the company has sufficient liquid assets to offset all
of its current liabilities, and
(4) Senticore's increased assets suggest that for the first time in the
history of the company, it will report a net profit for the second
quarter of 2006."
http://biz.yahoo.com/prnews/060628/law013.html?.v=63
power_forward72 - SNIO profits to be reported this quarter? Is that what I read? I think .10 could be a good target!
SNIO - Dividend NEWS - could run like PTSC!! .... Guess we can soon expect more PR's from this company!
Press Release Source: Senticore, Inc.
Senticore Announces Dividend and Application to Change Its Name to Integrative Health Technologies, Inc.
Wednesday June 28, 7:00 am ET
SAN ANTONIO, June 28 /PRNewswire-FirstCall/ -- Senticore, Inc. (OTC Bulletin Board: SNIO - News) has declared its first dividend in the history of the company. The cash dividend will be distributed to all shareholders of record on close of business on June 30, 2006. The amount and timing of the dividend will be based on funds derived from sale of its 882,353 shares in AdZone Research, Inc., which the company received December 29, 2004 from a joint venture transaction with AdZone. The acquisition and intent to dividend the shares was announced in the company's Security and Exchange Commission's filings of Forms 10-KSB for 2004 and 2005 and was contingent upon AdZone's registration of the shares or the application of Rule 144.
Dividend
"While questions may be raised as to the wisdom of distributing this asset as a dividend in light of the company's current liabilities and the absence of any net profits since the company was formed in 1999," said Gilbert R. Kaats, Senticore's CEO, "there were a number of considerations that led to this decision. These include:
(1) we wanted to honor the commitment the previous management made to the
shareholders,
(2) the business of AdZone does not fit Senticore's strategic focus on
healthcare and nutrition,
(3) a review of Senticore's financials for the second quarter of 2006 has
revealed that the company has sufficient liquid assets to offset all
of its current liabilities, and
(4) Senticore's increased assets suggest that for the first time in the
history of the company, it will report a net profit for the second
quarter of 2006."
Name Change
Application for a name change from Senticore to Integrative Health Technologies is consistent with Senticore's increased emphasis on the acquisition of healthcare and nutritional portfolio companies. Although incomplete at this time, additional information on the company's healthcare emphasis can be found on it website, www.ihtglobal.com .
Forward-Looking Statement: Statements that are not historical facts are forward-looking statements. The Company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are necessarily estimates reflecting the Company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors, factors that could cause actual results to differ materially from those estimated by the Company. They include, but are not limited to, government regulation, managing and maintaining growth, and the effect of adverse publicity, litigation, competition and other factors that may be identified from time to time in the Company's public announcements.
Contact Person: Gilbert R. Kaats or Samuel C. Keith
Senticore, Inc.
(210) 824.4416
A lot of loading on WTVN yesterday and today!